Bristol Myers Squibb (BMY)
NYSEHealth CareDrug Manufacturers - GeneralSnapshot 2026-09-04
$66.82-1.87%
Close 2026-09-04 · 1-day change
NYSEHealth CareDrug Manufacturers - GeneralSnapshot 2026-09-04
QuarterlyIQ Insights · BMY
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | 49,186.0 | 48,194.0 | 48,300.0 | 45,006.0 | 46,159.0 | 46,385.0 | 42,518.0 | 26,145.0 | 19,427.0 | 19,427.0 | 19,427.0 | 16,560.0 | 17,621.0 | 17,621.0 | 17,621.0 | 21,244.0 | 17,715.0 | 17,715.0 |
| Total Revenues | 49,186.0 | 48,194.0 | 48,300.0 | 45,006.0 | 46,159.0 | 46,385.0 | 42,518.0 | 26,145.0 | 19,427.0 | 19,427.0 | 19,427.0 | 16,560.0 | 17,621.0 | 17,621.0 | 17,621.0 | 21,244.0 | 17,715.0 | 17,715.0 |
| Cost of Revenues | 14,678.0 | 13,936.0 | 13,968.0 | 10,693.0 | 10,137.0 | 9,940.0 | 11,773.0 | 8,078.0 | 4,969.0 | — | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | 30,745.0 | 18,067.0 | 16,014.0 | 14,481.0 | 14,481.0 | 12,651.0 | 11,947.0 | 13,011.0 | 13,011.0 | 15,646.0 | 14,207.0 | — |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | 7,413.0 | 7,267.0 | 8,414.0 | 7,772.0 | 7,814.0 | 7,690.0 | 7,661.0 | 4,871.0 | 4,979.0 | 4,911.0 | 4,911.0 | 4,841.0 | 4,220.0 | 4,220.0 | 4,220.0 | 4,203.0 | 4,140.0 | 4,140.0 |
| R&D Expenses | 10,722.0 | 9,951.0 | 11,159.0 | 9,299.0 | 9,509.0 | 10,195.0 | 10,048.0 | 6,148.0 | 5,012.0 | 4,940.0 | 4,940.0 | 5,920.0 | 3,904.0 | 3,904.0 | 3,904.0 | 3,839.0 | 3,512.0 | 3,512.0 |
| Operating Income | — | — | — | 8,440.0 | 7,713.0 | 8,098.0 | (6,871.0) | 4,975.0 | 5,915.0 | 5,915.0 | 5,915.0 | 2,077.0 | 2,340.0 | 2,340.0 | 2,340.0 | 6,981.0 | 4,776.0 | 4,776.0 |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest Expense | — | 1,891.0 | 1,947.0 | 1,166.0 | 1,232.0 | 1,334.0 | 1,420.0 | 656.0 | 167.0 | 167.0 | 167.0 | 184.0 | 182.0 | 182.0 | 182.0 | 145.0 | 310.0 | — |
| Interest & Investment Income | 514.0 | 586.0 | 478.0 | 449.0 | 171.0 | 39.0 | 121.0 | 464.0 | 97.0 | 105.0 | 105.0 | 101.0 | 106.0 | 106.0 | 106.0 | 91.0 | 130.0 | — |
| Net Interest Expenses | — | — | — | 717.0 | 1,061.0 | 1,295.0 | 1,299.0 | 192.0 | 70.0 | 62.0 | 62.0 | 83.0 | 76.0 | 76.0 | 76.0 | 54.0 | 180.0 | — |
| Asset Writedown | — | — | — | — | — | — | — | 64.0 | 64.0 | 13.0 | 13.0 | — | — | — | 236.0 | 236.0 | 349.0 | 349.0 |
| EBT, Incl. Unusual Items | 11,910.0 | 9,328.0 | (8,379.0) | 8,440.0 | 7,713.0 | 8,098.0 | (6,871.0) | 4,975.0 | 5,915.0 | 5,915.0 | 5,915.0 | 2,077.0 | 2,340.0 | 2,340.0 | 2,340.0 | 6,981.0 | 4,776.0 | 4,776.0 |
| Income Tax Expense | 2,634.0 | 2,272.0 | 554.0 | 400.0 | 1,368.0 | 1,084.0 | 2,124.0 | 1,515.0 | 1,408.0 | 1,408.0 | 1,408.0 | 446.0 | (161.0) | (161.0) | (161.0) | 1,721.0 | 1,090.0 | 1,090.0 |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 5,260.0 | 3,686.0 | 3,686.0 |
| Net Income | ||||||||||||||||||
| Minority Interest | — | — | — | — | 18.0 | 20.0 | 20.0 | 21.0 | 50.0 | 50.0 | 50.0 | 66.0 | 541.0 | 541.0 | 541.0 | 1,551.0 | 996.0 | 996.0 |
| Net Income | 9,282.0 | 7,054.0 | (8,948.0) | 8,025.0 | 6,327.0 | 6,994.0 | (9,015.0) | 3,439.0 | 4,457.0 | 4,457.0 | 4,457.0 | 1,565.0 | 1,960.0 | 1,960.0 | 1,960.0 | 3,709.0 | 5,247.0 | 5,247.0 |
| Per Share | ||||||||||||||||||
| Basic EPS | 4.55 | 3.47 | (4.41) | 3.88 | 2.97 | 3.15 | (3.99) | 2.02 | 2.67 | 2.67 | 2.67 | 0.94 | 1.17 | 1.17 | 1.17 | 2.18 | 2.64 | 2.64 |
| Diluted EPS | 4.53 | 3.46 | (4.41) | 3.86 | 2.95 | 3.12 | (3.99) | 2.01 | 2.65 | 2.65 | 2.65 | 0.93 | 1.16 | 1.16 | 1.16 | 2.16 | 2.62 | 2.62 |
| Revenue per Share | 24.02 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 2.49 | 2.42 | 2.31 | 2.19 | 2.01 | 1.84 | 1.68 | 1.53 | 1.53 | 1.53 | 1.49 | 1.37 | 1.37 | 1.37 | 1.33 | 1.24 | 1.24 |
| Basic Weighted Avg Shares | 2,042.0 | 2,034.0 | 2,027.0 | 2,069.0 | 2,130.0 | 2,221.0 | 2,258.0 | 1,705.0 | 1,671.0 | 1,671.0 | 1,671.0 | 1,667.0 | 1,670.0 | 1,670.0 | 1,670.0 | 1,700.0 | — | — |
| Diluted Weighted Avg Shares | 2,048.0 | 2,039.0 | 2,027.0 | 2,078.0 | 2,146.0 | 2,245.0 | 2,258.0 | 1,712.0 | 1,680.0 | 1,680.0 | 1,680.0 | 1,679.0 | 1,688.0 | 1,688.0 | 1,688.0 | 1,717.0 | — | — |
| Supplemental | ||||||||||||||||||
| EBITDA | — | — | — | 18,200.0 | 17,989.0 | 18,784.0 | 3,509.0 | 6,721.0 | 6,297.0 | 6,297.0 | 6,297.0 | 2,453.0 | 3,021.0 | 3,021.0 | 3,021.0 | — | — | — |
| EBIT | — | — | — | 8,440.0 | 7,713.0 | 8,098.0 | (6,871.0) | 4,975.0 | 5,915.0 | 5,915.0 | 5,915.0 | 2,077.0 | 2,340.0 | 2,340.0 | 2,340.0 | 6,981.0 | 4,776.0 | 4,776.0 |
| Effective Tax Rate | 22.1% | — | — | 4.7% | 17.7% | 13.4% | -30.9% | 30.5% | 23.8% | 23.8% | 23.8% | 21.5% | -6.9% | -6.9% | -6.9% | 24.7% | 22.8% | 22.8% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.